The Vanguard Group Discloses Stake in Mural Oncology plc

The Vanguard Group, Inc. has disclosed its position in Mural Oncology plc under the Irish Takeover Panel rules. On November 25, 2025, Vanguard held 1.41% of Mural Oncology's $0.01 ordinary shares, totaling 242,973 shares. This disclosure follows Rule 8.3 of the Irish Takeover Panel Act, 1997, enabling transparency in the interests of firms with significant stakes in public companies.

The deal involved a minor sale of 32 shares at a price of $2.09 each. No other transactions, like options or derivatives, were reported on the disclosure form. Additionally, no indemnity or other arrangements were noted by Vanguard in relation to Mural Oncology securities.

This position disclosure forms part of the routine transparency measures in financial markets, providing insights into the strategic interests and movements of major institutional investors like The Vanguard Group.